drugset / Trial / NCT03616236

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

NCT03616236

Phase 3 Suspended 320 enrolled Friends Research Institute, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Timeline

Start
2022-07-01
Primary completion
2026-08-31
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified
Background Naloxone Small molecule